October 2020 PMID 32967006

SARS-CoV-2 vaccines in development.

Florian Krammer

Full text PDF Download social card

Mentions

125

Peak: 14 in Nov 2020

across 7 sources since Sep 2020

Extended reach

256,802

potential audience

Total likes

174

Video views

6,351

Mentions per month

Sep 2020 – Sep 2025

Where it's discussed

News58 articles
X / Twitter37 posts
Facebook11 posts
Blogs11 articles
YouTube5 videos
Reddit2 posts
Bluesky1 posts

AI synopsis

What people are saying

The overall tone reflects a high level of interest and engagement, exemplified by references to authoritative sources like the article in Nature and mentions of vaccine efficacy and safety data. Vocabulary like 'effective and safe vaccines might become available within months' and phrases such as 'the challenge of vaccine development' highlight the significance and optimism surrounding the research, leading to a positive view of its impact.

AgreementModerate agreement

Most discussions express optimism about the rapid development of effective vaccines, with references to studies and reputable sources, indicating general agreement with the publication's positive outlook.

InterestHigh interest

The discussions show high interest, with mentions of vaccine efficacy, safety, and development timelines, along with references to scientific articles and trials.

EngagementModerate engagement

Many posters actively reference specific studies, like the article by Krammer, and discuss implications, showing a willingness to analyze and share information deeply.

ImpactModerate impact

The focus on vaccine development timelines and efficacy suggests these discussions perceive the research as having a moderate to high influence on public health strategies.

Abstract in brief

SARS-CoV-2, which causes COVID-19, was first identified in late 2019 in China, leading to a global pandemic, and vaccine development started rapidly after the virus's genetic sequence was shared in early 2020.
Multiple vaccine candidates have progressed through different stages of clinical trials, with some already in phase III, indicating promising safety and efficacy data.
The swift development process suggests that effective vaccines could be available within a few months, rather than several years, to help control the pandemic.]

Read the full abstract

All mentions

Insights on mRNA Vaccines for COVID-19 and Their Impact

This video provides an overview of mRNA vaccines in the fight against COVID-19, along with the virus's mechanics and mutations. Key milestones in vaccine development and safety will also be discussed, ensuring you stay…

Röbbe Wünschiers · Jan 11, 2021 3,152 views

Which COVID-19 Vaccine Is the Most Effective?

COVID-19 vaccines like Pfizer, AstraZeneca, and Coronavac are available in Brazil. Learn about their differences, effectiveness, and which vaccine might be best for you based on current scientific understanding.

Academia · Jul 10, 2021 1,398 views

Comparing COVID-19 Vaccines and Treatments: Key Insights

This video discusses the differences between COVID-19 vaccines and treatments. It highlights the global effort to find effective therapies like the REGN-COV2 antibody cocktail, which shows promise in reducing virus…

Science Broadcast by Viet Hang · Nov 1, 2020 1,016 views

REGN-COV2 Antibodies: Effective COVID-19 Treatment Insights

A global effort is underway to find effective treatments for COVID-19, focusing on the antibody cocktail REGN-COV2. This video explores how REGN-COV2 significantly reduces virus levels in animal models, providing…

Science Broadcast by Viet Hang · Nov 6, 2020 543 views

Development of SARS-CoV-2 Vaccines and Clinical Trial Stages

This video reviews the development of COVID-19 vaccines, highlighting the various platforms and clinical trial phases. It aims to enhance understanding of vaccine progress and its role in controlling the pandemic.

abdulloh suyuti · Apr 19, 2021 243 views

Maegan Laporte unacceptable independent

@maegan_laporte · X

RT @IntegralAnswers: 9/

Sep 15, 2025 · 1 share · 5,650 followers View post →

IntegralAnswers

@IntegralAnswers · X

Sep 15, 2025 · 5 likes · 1 share · 7,763 followers View post →

Valentin Muro

@valenzine · X

@darioalturria @cenitalcom https://t.co/1qxyqRvnAH https://t.co/xksfe1qesq

Sep 12, 2025 · 28,801 followers View post →

Stephanie Mathis, MLS(ASCP)

@stephmu00mls.bsky.social · Bluesky

Your wish is my command!

Feb 22, 2025 · 1 share View post →

Peter Voshol

@Peter_Voshol · X

RT @SchoofsLiliane: @HoeyberghsJeff En https://t.co/siZ4Byrrdi

Jan 8, 2024 · 1 share · 1,923 followers View post →

Tat Yana

@Tat_Yana_13 · X

SARS-CoV-2 vaccines in development | Nature https://t.co/ULMcucytYK

Nov 17, 2023 · 17 followers View post →

Kevin Terán De la Sancha

@terandelasancha · X

@CosasCagadas95 @sawasnator @GlodeJo07 La vacuna Abdala no cuenta con los ensayos descritos anteriormente y que son de carácter universal. Te comparto el siguiente artículo sobre el proceso de fabricación de vacunas. https://t.co/HGNW8LWTOx

May 12, 2022 · 316 followers View post →

Liliane Schoofs

@SchoofsLiliane · X

@HoeyberghsJeff En https://t.co/siZ4Byrrdi

Dec 25, 2021 · 17 likes · 1 share · 7,849 followers View post →

SciCo-Dad

@SciCoDad · X

Dec 14, 2021 · 3 likes · 268 followers View post →

Isatou Sarr

@IsatouSarr4 · X

phase III trials. The data available so far suggest that effective and safe vaccines might become available within months, rather than years. https://t.co/vIQNiCvImw

Mar 5, 2021 · 1 like · 34 followers View post →

Ricardo Tróstel Provoste

@RicardoTrostelP · X

RT @XxTurok: @PedroRomvill @TrostelxConce https://t.co/AdXsXwoATd. La publicación de la Nature (revista tremendamente destacada en ciencia)…

Feb 25, 2021 · 1 share · 12,349 followers View post →

Arturo Trostel

@XxTurok · X

@PedroRomvill @TrostelxConce https://t.co/AdXsXwoATd. La publicación de la Nature (revista tremendamente destacada en ciencia) con su respectivo paper de la pubmed. https://t.co/I9C76GxL07

Feb 25, 2021 · 1 like · 1 share · 200 followers View post →

Isatou Sarr

@IsatouSarr4 · X

effective and safe vaccines might become available within months, rather than years. https://t.co/vIQNiCvImw

Feb 10, 2021 · 1 like · 34 followers View post →

Josep M Llibre

@DrBike7 · X

Will COVID vaccines protect transmission?: Animal studies suggest that Moderna and A-Z offer no protection in upper resp tract. Sinovac, Beijing and Novavax only partial protection. Only Janssen would offer complete protection. Found no data with Pfizer https://t.co/HfIIRUUY9z

Jan 25, 2021 · 1 like · 739 followers View post →

James Callahan

@nursejcallahan · X

@kateraider This is a favourite of mine: maybe you can read it and share at your own workplace

Jan 21, 2021 · 1,178 followers View post →

Francisco J. Rivera-Gálvez

@DrFranciscoRG · X

Referencias. 1.- Krammer, F. SARS-CoV-2 vaccines in development. Nature 586, 516–527 (2020). https://t.co/KLsQDzuqh3 2.- Kaur S.P., Gupta V. COVID-19 Vaccine: A comprehensive status report. Virus research. 2020. https://t.co/iiLovR6jst (14/14)

Jan 14, 2021 · 1 like · 103 followers View post →

Francisco J. Rivera-Gálvez

@DrFranciscoRG · X

Dec 22, 2020 · 1 like · 103 followers View post →

Mirko Junge

@DrJunge · X

Es ist der Krammer, der den SARS-CoV-2 Impfstoff Übersichtsartikel in Nature geschrieben hat. doi:10.1038/s41586-020-2798-3 Vom 23.9.2020. https://t.co/hgN9EQr3DU

Nov 27, 2020 · 142 followers View post →

Hans Sars

@HansSars · X

Sars 2 Vaccine https://t.co/Klx9gEgypd

Nov 20, 2020 · 31 followers View post →

CHSeaton

@COSseaton · X